Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.

Faculty

Karine Lacombe, MD, PhD

Professor of Infectious Diseases
Sorbonne Université
Head of the Infectious Diseases Unit
St Antoine Hospital
Institute Pierre-Louis de Santé Publique
Paris, France

Disclosures

Karine Lacombe, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Diaccurate; Gilead Sciences; Janssen; Merck Sharp Dohme; Moderna; Spikimm; ViiV Healthcare
Research funding from: Merck Sharp Dohme
Owns bonds from: Spikimm

Jörg Schelling, MD

Professor of General Practice and Family Medicine
LMU Munich
Munich, Germany

Disclosures

Jörg Schelling, MD, has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bavarian Nordic; GlaxoSmithKline; Janssen; Merck Sharp Dohme; Pfizer; Sanofi Pasteur; Seqirus
Speaker or member of speakers bureau for: AstraZeneca; Bavarian Nordic; GlaxoSmithKline; Janssen; Merck Sharp Dohme; Mylan; Pfizer; Sanofi Pasteur; Seqirus

Anna Goodman, FRCP

Consultant in Infectious Disease
Honorary Associate Professor
Guy’s and St Thomas’ NHS Foundation Trust
London, United Kingdom

Disclosures

Anna Goodman, FRCP, has the following relevant financial relationships:
Research funding from: Novavax
Patent beneficiary of: Patent for COVID vaccines held by the University of Oxford for technology, which is used in the AstraZeneca COVID vaccine.

Editors

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Shanthi Voorn, PhD, has no relevant financial relationships.

Eloise Ballard, PhD

Scientific Content Manager, WebMD Global, LLC

Disclosures

Eloise Ballard, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

COVID-19 Vaccine Clinical Compendium: Comparing Vaccines, Safety Status, and Future Perspectives

Authors: Karine Lacombe, MD, PhD; Jörg Schelling, MD; Anna Goodman, FRCP
CME Released: 12/22/2022
Valid for credit through: 12/22/2023

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US primary care practitioners, infectious disease / HIV specialists, pediatricians, public health and preventive medicine specialists, nurses, and pharmacists.

The goal of this activity is to increase knowledge of the similarities and differences in safety and efficacy of available COVID-19 vaccines.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Efficacy data for new COVID-19 vaccine
- Tolerability profile of newly available vaccines
Demonstrate greater confidence in their ability to
- Communicate with patients the need for boosters with COVID-19 vaccines

Disclosures

Disclosures for additional planners can be found here.

Faculty

Karine Lacombe, MD, PhD

Professor of Infectious Diseases
Sorbonne Université
Head of the Infectious Diseases Unit
St Antoine Hospital
Institute Pierre-Louis de Santé Publique
Paris, France

Disclosures

Karine Lacombe, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Diaccurate; Gilead Sciences; Janssen; Merck Sharp Dohme; Moderna; Spikimm; ViiV Healthcare
Research funding from: Merck Sharp Dohme
Owns bonds from: Spikimm

Jörg Schelling, MD

Professor of General Practice and Family Medicine
LMU Munich
Munich, Germany

Disclosures

Jörg Schelling, MD, has the following relevant financial relationships:
Consultant or advisor for: AstraZeneca; Bavarian Nordic; GlaxoSmithKline; Janssen; Merck Sharp Dohme; Pfizer; Sanofi Pasteur; Seqirus
Speaker or member of speakers bureau for: AstraZeneca; Bavarian Nordic; GlaxoSmithKline; Janssen; Merck Sharp Dohme; Mylan; Pfizer; Sanofi Pasteur; Seqirus

Anna Goodman, FRCP

Consultant in Infectious Disease
Honorary Associate Professor
Guy’s and St Thomas’ NHS Foundation Trust
London, United Kingdom

Disclosures

Anna Goodman, FRCP, has the following relevant financial relationships:
Research funding from: Novavax
Patent beneficiary of: Patent for COVID vaccines held by the University of Oxford for technology, which is used in the AstraZeneca COVID vaccine.

Editors

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Shanthi Voorn, PhD, has no relevant financial relationships.

Eloise Ballard, PhD

Scientific Content Manager, WebMD Global, LLC

Disclosures

Eloise Ballard, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.